MNG
BMY icon

Manning & Napier Group’s Bristol-Myers Squibb BMY Stock Holding History

Manning & Napier Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$23.1M Sell
425,781
-36,470
-8% -$1.86M 0.26% 78
2023
Q4 		$23.7M Sell
462,251
-71,686
-13% -$3.76M 0.28% 81
2023
Q3 		$31M Sell
533,937
-18,539
-3% -$1.14M 0.38% 69
2023
Q2 		$35.3M Buy
552,476
+60,974
+12% +$4.09M 0.4% 70
2023
Q1 		$34.1M Sell
491,502
-344
-0.1% -$24.3K 0.4% 64
2022
Q4 		$35.4M Sell
491,846
-4,445
-0.9% -$335K 0.44% 60
2022
Q3 		$35.3M Sell
496,291
-9,245
-2% -$671K 0.46% 55
2022
Q2 		$38.9M Sell
505,536
-118,439
-19% -$9.02M 0.45% 58
2022
Q1 		$45.6M Sell
623,975
-48,695
-7% -$3.27M 0.43% 67
2021
Q4 		$41.9M Sell
672,670
-34,139
-5% -$2M 0.35% 72
2021
Q3 		$41.8M Sell
706,809
-7,427
-1% -$489K 0.36% 75
2021
Q2 		$47.7M Buy
714,236
+109,944
+18% +$7.17M 0.39% 76
2021
Q1 		$38.1M Buy
604,292
+14,757
+3% +$918K 0.32% 87
2020
Q4 		$36.6M Sell
589,535
-43,038
-7% -$2.65M 0.34% 83
2020
Q3 		$38.1M Buy
632,573
+5,875
+0.9% +$354K 0.39% 73
2020
Q2 		$36.8M Buy
626,698
+33,979
+6% +$2.03M 0.39% 69
2020
Q1 		$33M Buy
592,719
+88,717
+18% +$5.42M 0.39% 67
2019
Q4 		$32.4M Buy
504,002
+32,033
+7% +$1.83M 0.35% 77
2019
Q3 		$23.9M Buy
471,969
+2,096
+0.4% +$98.5K 0.27% 94
2019
Q2 		$21.3M Buy
469,873
+123,718
+36% +$5.76M 0.23% 99
2019
Q1 		$16.5M Sell
346,155
-1,217,950
-78% -$60.7M 0.18% 106
2018
Q4 		$81.3M Sell
1,564,105
-6,418
-0.4% -$345K 0.99% 33
2018
Q3 		$97.5M Buy
1,570,523
+17,406
+1% +$1.03M 0.96% 37
2018
Q2 		$85.9M Buy
1,553,117
+230,707
+17% +$12.5M 0.85% 40
2018
Q1 		$83.6M Sell
1,322,410
-476,091
-26% -$30.6M 0.82% 39
2017
Q4 		$110M Buy
+1,798,501
New +$112M 0.99% 36

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manning & Napier Group's BMY Position: Q1 2024 in Review

Manning & Napier Group reduced its Bristol-Myers Squibb (BMY) stake by 7.9% in Q1 2024, selling an estimated $1.86M and leaving 425,781 shares worth $23.1M. The position accounts for 0.26% of the portfolio, ranked #78.

Manning & Napier Group first reported a position in BMY in Q4 2017 and has held it in 26 quarters since. The position peaked at $110M in Q4 2017. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Manning & Napier Group held 425,781 shares of Bristol-Myers Squibb worth $23.1M as of Q1 2024.
  • Manning & Napier Group sold 36,470 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.86M.
  • Bristol-Myers Squibb made up 0.26% of Manning & Napier Group's portfolio in Q1 2024, its #78 holding.
  • Manning & Napier Group first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 26 quarters since.
  • Manning & Napier Group's Bristol-Myers Squibb position peaked at $110M in Q4 2017.
  • 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.